A structured programme to withdraw antipsychotics among adults with intellectual disabilities: The Cornwall experience.
Saved in:
| Title: | A structured programme to withdraw antipsychotics among adults with intellectual disabilities: The Cornwall experience. |
|---|---|
| Authors: | Shankar, Rohit (AUTHOR), Wilcock, Mike (AUTHOR), Deb, Shoumitro (AUTHOR), Goodey, Rebecca (AUTHOR), Corson, Eve (AUTHOR), Pretorius, Charlotte (AUTHOR), Praed, Georgina (AUTHOR), Pell, Amanda (AUTHOR), Vujkovic, Dee (AUTHOR), Wilkinson, Ellen (AUTHOR), Laugharne, Richard (AUTHOR), Axby, Sharon (AUTHOR), Sheehan, Rory (AUTHOR), Alexander, Regi (AUTHOR) |
| Source: | Journal of Applied Research in Intellectual Disabilities. Nov2019, Vol. 32 Issue 6, p1389-1400. 12p. |
| Subjects: | Antipsychotic agents, Caregivers, Hospital admission & discharge, Patient aftercare, People with intellectual disabilities, Patients, Detoxification (Substance abuse treatment), Human services programs, Stakeholder analysis |
| Abstract: | Background: Antipsychotic medications are used among 19%–58% of adults with intellectual disabilities to manage challenging behaviour against the NICE guideline recommendations. Studies show that it is possible to completely withdraw antipsychotics in about one third of adults with intellectual disabilities and a dose reduction of 50% or more in another third. Method: In Cornwall, over three years the present authors developed a structured pathway to withdraw antipsychotics among adults with intellectual disabilities which involved people with intellectual disabilities and their carers, GPs, community learning disability team members and pharmacists. Results: The present authors managed to withdraw antipsychotics totally among 46.5% (33/71) and reduced over 50% of dosage in another 11.3% (8/71) of adults with intellectual disabilities. At three months follow‐up no one required hospital admission or change in placement. Conclusion: It is possible to withdraw/reduce antipsychotics in a high proportion of adults with intellectual disabilities if a concerted effort is made involving all stakeholders from the outset. [ABSTRACT FROM AUTHOR] |
| Copyright of Journal of Applied Research in Intellectual Disabilities is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Background: Antipsychotic medications are used among 19%–58% of adults with intellectual disabilities to manage challenging behaviour against the NICE guideline recommendations. Studies show that it is possible to completely withdraw antipsychotics in about one third of adults with intellectual disabilities and a dose reduction of 50% or more in another third. Method: In Cornwall, over three years the present authors developed a structured pathway to withdraw antipsychotics among adults with intellectual disabilities which involved people with intellectual disabilities and their carers, GPs, community learning disability team members and pharmacists. Results: The present authors managed to withdraw antipsychotics totally among 46.5% (33/71) and reduced over 50% of dosage in another 11.3% (8/71) of adults with intellectual disabilities. At three months follow‐up no one required hospital admission or change in placement. Conclusion: It is possible to withdraw/reduce antipsychotics in a high proportion of adults with intellectual disabilities if a concerted effort is made involving all stakeholders from the outset. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 13602322 |
| DOI: | 10.1111/jar.12635 |
